U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07899892) titled 'A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer' on Oct. 21.
Brief Summary: The purpose of this study is to find out whether it is practical (feasible) to use a new type of imaging scan called 68Ga-FAPI PET/MRI (positron emission tomography/magnetic resonance imaging) to evaluate how well breast cancer responds to neoadjuvant chemotherapy.
Study Start Date: Oct. 20
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Invasive Breast Cancer
Intervention:
DIAGNOSTIC_TEST: 68Ga-FAPI-PET/MRI
68Ga-FAPI-PET/MRI is conducted 3 times in every participant.
Recruitment Status: RECRUITING
Sponsor: Memorial Sloan ...